Heinrich Haas

Heinrich Haas

Company: NeoVac

Job title: Chief Technology Officer

Seminars:

Formulation Technologies for Delivery of RNA by LNPs & Other Nanoparticles 3:00 pm

Nanoparticles for RNA delivery need to be tailored for a given therapeutic intervention Parameters to be optimized comprise molecular characteristics, structure, size, immunogenicity and (surface) functionalization Novel LNPs and other nanoparticle formats can be eligible for such purposesRead more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.